blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2631237

EP2631237 - Total synthesis of salinosporamide A and analogs thereof [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  21.03.2014
Database last updated on 27.07.2024
Most recent event   Tooltip21.03.2014Application deemed to be withdrawnpublished on 23.04.2014  [2014/17]
Applicant(s)For all designated states
Nereus Pharmaceuticals, Inc.
10480 Wateridge Circle
San Diego, CA 92121 / US
[2013/35]
Inventor(s)01 / Ling, Taotao
9138 Regents Road, Apt. K
La Jolla, CA California 92037 / US
02 / Macherla, Venkata, Rami, Reddy
10868 Caminito Arcada
San Diego, CA California 92131 / US
03 / Potts, Barbara, Christine
2029 Oro Verde Road
Escondido, CA California 92029 / US
04 / Manam, Rama, Rao
11633-3 Compass Point Drive
San Diego, CA California 92126 / US
05 / McArthur, Katherine
4534 71st Street
La Mesa, CA California 91941 / US
 [2013/35]
Representative(s)Grund, Martin, et al
Grund Intellectual Property Group
Patentanwälte und Solicitor PartG mbB
Steinsdorfstraße 2
80538 München / DE
[N/P]
Former [2013/35]Grund, Martin, et al
Grund
Intellectual Property Group
Postfach 44 05 16
80754 München / DE
Application number, filing date12171505.606.04.2007
[2013/35]
Priority number, dateUS20060790168P06.04.2006         Original published format: US 790168 P
US20060816968P27.06.2006         Original published format: US 816968 P
US20060836155P07.08.2006         Original published format: US 836155 P
US20060844132P12.09.2006         Original published format: US 844132 P
US20070885379P17.01.2007         Original published format: US 885379 P
[2013/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP2631237
Date:28.08.2013
Language:EN
[2013/35]
ClassificationIPC:C07D491/048, C07D207/28
[2013/35]
CPC:
C07D491/048 (EP,US); C07D207/26 (KR); A61P29/00 (EP);
A61P31/04 (EP); A61P35/00 (EP); A61P43/00 (EP);
C07D207/28 (EP,US); C07D263/04 (KR); C07D491/04 (KR);
C07D498/04 (KR); Y02P20/55 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2013/35]
TitleGerman:Totalsynthese von Salinosporamid A und Analoga davon[2013/35]
English:Total synthesis of salinosporamide A and analogs thereof[2013/35]
French:Synthèse totale de Salinosporamide A et de ses Analogues[2013/35]
Examination procedure01.11.2013Application deemed to be withdrawn, date of legal effect  [2014/17]
10.12.2013Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2014/17]
Parent application(s)   TooltipEP07754986.3  / EP2013167
Fees paidRenewal fee
11.06.2012Renewal fee patent year 03
11.06.2012Renewal fee patent year 04
11.06.2012Renewal fee patent year 05
11.06.2012Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.04.201307   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inby applicantUS5874443
 US5886210
 US5922683
 US6350759
 US6500825
 US6506787
 US6509331
 US7144723
 US7176232
    - OKAMI, Y., J MAR BIOTECHNOL, (1993), vol. 1, page 59
    - BULL, A.T. ET AL., MICROBIOL MAL BIOL REV, (2000), vol. 64, page 573
    - CRAGG, G.M.; D.J. NEWMAN, TRENDS PHARMACOL SCI, (2002), vol. 23, page 404
    - KERR, R.G.; S.S. KERR, EXP OPIN THER PATENTS, (1999), vol. 9, page 1207
    - MOORE, B.S, NAT PROD REP, (1999), vol. 16, page 653
    - FAULKNER, D.J., NAT PROD REP, (2001), vol. 18, page 1
    - MAYER, A. M.; V.K. LEHMANN, ANTICANCER RES, (2001), vol. 21, page 2489
    - HABIBI ET AL., MOLECULES, (2003), vol. 8, pages 663 - 9
 US20040627461
 US20040871368
 WO2004US19543
 US20040633379
 US20050643922
 US20050658884
 US20050676533
 US20050118260
 WO2005US14846
 WO2005US44091
 US20060412476
 WO2006US16104
 US20060453374
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.